Katemera wa COVID-19 wopangidwa ndi Sinopharm waku China kuti agwiritsidwe ntchito mwadzidzidzi, wovomerezeka ndi WHO.

Katemera wa COVID-19 wopangidwa ndi Sinopharm waku China

zogwiritsidwa ntchito mwadzidzidzi, zovomerezeka ndi WHO.

TheWorld Health Organisation (WHO)adavomerezeka pa Meyi 7 katemera wa BBIBP-CorV COVID-19 wopangidwa ndi Sinopharm yaku China kuti agwiritsidwe ntchito mwadzidzidzi.

Madzulo ano, WHO idapereka mndandanda wadzidzidzi wa katemera wa Sinopharm Beijing wa COVID-19, zomwe zidapangitsa kukhala katemera wachisanu ndi chimodzi kulandira chitsimikiziro cha WHO pachitetezo, champhamvu komanso chamtundu, "atero Director-General wa WHO Dr. Tedros Adhanom Ghebreyesus pamsonkhano wa atolankhani.

Izi zimakulitsa mndandanda wa katemera omwe COVAX ingagule, ndikupatsanso maiko chidaliro chofulumizitsa kuvomereza kwawo, komanso kuitanitsa ndi kupereka katemera.

 

Ndi ulemu waukulu umenewoBioendo's endotoxin test solutionamathandizira kuwongolera kwamtundu wa endotoxin kuzindikira pakupanga ndi kupanga katemera wa COVID-19 ku China.

Tikukhulupirira kuti anthu padziko lonse lapansi adzasangalala ndi nthawi yamtendere komanso moyo wabwino.

 

·Nkhaniyi yagwira mawu ochokera ku China Daily Bilingual News.